SK Capital Partners, a private investment firm focusing on specialty materials, ingredients, and life sciences, has announced the successful closure of SKCP Catalyst Fund II. The Fund garnered a total committed capital of $800 million, exceeding its $750 million hard cap on Limited Partner commitments. Additionally, SK Capital contributed an extra $50 million to the Fund.
The firm’s investment process is applied uniformly across its entire portfolio, with two parts of the SK Capital fund family: Flagship and Catalyst. The Flagship strategy targets upper mid-sized and large companies, while the Catalyst strategy, established in 2019, focuses on lower middle market companies. With seven funds raised since its inception in 2007, SK Capital now manages over $7.8 billion in assets under both Flagship and Catalyst strategies.
Barry Siadat, Co-Founder and Managing Director of SK Capital, expressed gratitude to Limited Partners for their support and emphasized the Firm’s commitment to delivering value across various deal sizes in their chosen sectors. Catalyst Fund II centers on transformative buyout investments requiring initial equity capital of up to $100 million. Its predecessor, Catalyst Fund I, had aggregate commitments of about $415 million and made eight platform investments, with significant realizations in NuCera Solutions and Techmer PM.
The Catalyst investment team, led by Managing Directors Mario Toukan and Jon Borell, comprises thirteen professionals with extensive experience in the firm’s target sectors. They utilize SK Capital’s vast resources to create and capture value sustainably for all stakeholders.
Mario Toukan, Managing Director of SK Capital, expressed appreciation for the unwavering support from both new and long-standing investors, highlighting their partnership in building exceptional companies within their chosen sectors.
SK Capital is dedicated to building resilient, sustainable, and growing businesses that generate long-term economic value. Their portfolio of businesses generates an annual revenue of approximately $17 billion, employs over 25,000 people globally, and operates in more than 30 countries.
Keywords: SK Capital Partners, Catalyst Fund II, private investment firm, specialty materials, ingredients, life sciences, Fund closure, limited partner commitments, investment strategies, buyout investments, sustainable growth, value creation, assets under management, business transformation.
